BANK OF MONTREAL /CAN/ - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 169 filers reported holding AMNEAL PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.27 and the average weighting 0.2%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$30,980
-26.2%
13,296
+93.3%
0.00%
Q1 2021$42,000
-41.7%
6,878
-54.9%
0.00%
Q4 2020$72,000
+278.9%
15,260
+233.0%
0.00%
Q3 2020$19,000
-70.3%
4,582
-68.4%
0.00%
Q2 2020$64,000
+433.3%
14,490
+271.3%
0.00%
Q1 2020$12,000
-83.3%
3,902
-73.8%
0.00%
Q4 2019$72,000
+200.0%
14,913
+81.5%
0.00%
Q3 2019$24,000
-60.0%
8,216
-3.1%
0.00%
Q2 2019$60,000
-6.2%
8,475
+87.5%
0.00%
Q1 2019$64,000
-85.6%
4,521
-86.2%
0.00%
Q4 2018$444,000
-37.7%
32,755
+2.0%
0.00%
-100.0%
Q3 2018$713,000
+31.8%
32,128
-2.6%
0.00%
Q2 2018$541,00032,9690.00%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$144,839,00011.40%
Eversept Partners, LP 4,755,480$32,004,3802.41%
TPG Group Holdings (SBS) Advisors, Inc. 16,213,367$109,116,0001.27%
EAM Global Investors LLC 365,719$2,461,0000.68%
Signature Wealth Management Partners, LLC 87,666$590,0000.57%
Jackson Creek Investment Advisors LLC 221,043$1,488,0000.52%
Tranquilli Financial Advisor LLC 71,414$481,0000.39%
Hillsdale Investment Management Inc. 611,200$4,113,0000.34%
EAM Investors, LLC 259,873$1,749,0000.26%
HUSSMAN STRATEGIC ADVISORS, INC. 180,000$1,211,0000.25%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders